Creative Biolabs supplies cell therapy products, human gene therapy products and certain devices related to cell and gene therapy. Our latest approach for genetically engineered cell therapy is currently exploring the use of engineered T cells, NK cells, macrophage or cytokine-induced killer cells to induce an effective immune response in cancer cells or viruses, and regulatory T cells to regulate inflammation.

Next™ CAR-T Engineering Platform

Different types of cells can be employed to develop genetically engineered cell therapies and consequently inducing immune responses to tumor cells. Technically, genomic editing technology offers the possibility of designing such general-purpose donor cells in a controlled manner. We provide the following technologies but not limited to these.

With the cell and gene therapy lifecycle infrastructure and our expert team, Creative Biolabs are capable of offering multiple engineering services in cellular and gene therapy. We have a number of strategies to help you deal with the challenges that you may encounter in the development of cell and gene therapy. The cell and gene therapy will be safer, more effective, scalable and affordable if we can paly a part in accelerating your project. Our work is to stay ahead of the latest innovations in cell and gene therapy thus we are at your disposal anytime.

Please feel free to contact us and our team will contact you as soon as possible.

For Research Use Only | Not For Clinical Use

Related Services

• TCR Design Construction and Plasmid GLP Production
• CAR Design Construction and Plasmid GLP Production
• TCR-T and CAR-T NK MA Cell GLP Production
• TCR-T and CAR-T NK/MA Cell Activation and Expansion
• Genetic Modification
• Programming CAR Technologies
• Virus GLP Production
• Transfection Technologies